Projected Income Statement: Silicon Laboratories Inc.

Forecast Balance Sheet: Silicon Laboratories Inc.

Fiscal Period: January 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -1,589 -662 -394 -382 -444 -388 -677 -828
Change - 58.34% 40.48% 3.05% -16.23% 12.54% -74.48% -22.3%
Announcement Date 2/2/22 2/1/23 2/7/24 2/4/25 2/4/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Silicon Laboratories Inc.

Fiscal Period: January 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 28.58 26.52 22.28 11.75 29.92 47.49 53.68
Change - -7.18% -16% -47.28% 154.7% 58.72% 13.03%
Free Cash Flow (FCF) 1 62.62 114.7 -52.63 -25.66 65.79 -6 271
Change - 83.24% -145.87% 51.25% 356.4% -109.12% 4,616.67%
Announcement Date 2/2/22 2/1/23 2/7/24 2/4/25 2/4/26 - -
1USD in Million
Estimates

Forecast Financial Ratios: Silicon Laboratories Inc.

Fiscal Period: January 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 17.72% 23.14% 11.61% -9.21% 6.37% 15.64% 17.17% 15.94%
EBIT Margin (%) 15.21% 20.94% 8.33% -13.58% 3.22% 12.12% 16.53% 13.66%
EBT Margin (%) -8.07% 12.35% -1.35% -26.49% -7.38% -3.16% 3.74% -
Net margin (%) 293.73% 8.93% -4.41% -32.69% -8.27% -4.35% 1.14% -
FCF margin (%) 8.69% 11.2% -6.73% -4.39% 8.38% -0.65% 25.1% -
FCF / Net Income (%) 2.96% 125.54% 152.48% 13.43% -101.35% 14.89% 2,196.83% -

Profitability

        
ROA - - 2.99% -4.12% 2.44% 7.57% 10.79% -
ROE 8.02% 9.4% 4.13% -4.8% 2.79% 8.72% 12.09% 11.4%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 3.96% 2.59% 2.85% 2.01% 3.81% 5.12% 4.97% -
CAPEX / EBITDA (%) 22.38% 11.19% 24.53% -21.82% 59.82% 32.74% 28.95% -
CAPEX / FCF (%) 45.63% 23.12% -42.34% -45.79% 45.48% -791.54% 19.81% -

Items per share

        
Cash flow per share 1 - - - -0.4321 2.925 - - -
Change - - - - 776.93% - - -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 57.49 43.91 37.89 33.55 33.45 33.56 41.34 45.36
Change - -23.62% -13.72% -11.45% -0.31% 0.33% 23.17% 9.74%
EPS 1 47.78 2.54 -1.09 -5.93 -1.98 -1.205 0.3608 -
Change - -94.68% -142.91% -444.04% 66.61% 39.16% 129.95% -
Nbr of stocks (in thousands) 40,187 33,283 31,779 32,448 32,853 33,367 33,367 33,367
Announcement Date 2/2/22 2/1/23 2/7/24 2/4/25 2/4/26 - - -
1USD
Estimates
2026 *2027 *
P/E -182x 607x
PBR 6.53x 5.3x
EV / Sales 7.46x 6.14x
Yield - -

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
219.05USD
Average target price
222.86USD
Spread / Average Target
+1.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SLAB Stock
  4. LA5 Stock
  5. Financials Silicon Laboratories Inc.